• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Tenon Medical Inc.

    8/8/24 4:07:29 PM ET
    $TNON
    Medical/Dental Instruments
    Health Care
    Get the next $TNON alert in real time by email
    SC 13G 1 kovitztenon13g8824.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ________)* Tenon Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 88066N204 (CUSIP Number) Jeremy Wilson, Kovitz Investment Group Partners LLC; 71 South Wacker Drive, Ste 11860 Chicago, IL 60606 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) 07/01/2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ? Rule 13d-1(b) XX ? based on IA status. ? Rule 13d-1(c) ? Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ? CUSIP No. 88066N204 13G Page 2 of 3 Pages Kovitz Investment Group, LLC 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 47-5657416 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ? (b) ? 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 * Kovitz does not have proxy voting authority over client accounts. 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 939,888* assumes warrants held by Kovitz clients exercised. 8. SHARED DISPOSITIVE POWER 939,888 * assumes warrants held by Kovitz clients exercised. 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 939,888 * assumes warrants held by Kovitz clients exercised. 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ? 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 21.89% 12. TYPE OF REPORTING PERSON (see instructions) IA Item 1. (a) Name of Issuer: Tenon Medical, Inc. (b) Address of Issuer?s Principal Executive Offices 104 Cooper Court, Los Gatos, CA 95032 Item 2. (a) Name of Person Filing Kovitz Investment Group Partners, LLC (b) Address of the Principal Office or, if none, residence 71 S. Wacker Drive, Suite 1860, Chicago, IL 60606 CUSIP No. 88066N204 13G Page 3 of 3 Pages (c) Citizenship USA (d) Title of Class of Securities Common Stock (e) CUSIP Number 88066N204 Item 3. If this statement is filed pursuant to ??240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) ? Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) ? Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) ? Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) ? Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). XX (e) ? An investment adviser in accordance with ?240.13d- 1(b)(1)(ii)(E); (f) ? An employee benefit plan or endowment fund in accordance with ?240.13d-1(b)(1)(ii)(F); (g) ? A parent holding company or control person in accordance with ?240.13d-1(b)(1)(ii)(G); (h) ? A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) ? A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) ? Group, in accordance with ?240.13d-1(b)(1)(ii)(J). Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 939,888 * assumes warrants held by Kovitz clients exercised (b) Percent of class: 21.89% (c) Number of shares as to which the person has: 939,888 (i) Sole power to vote or to direct the vote . 0 (ii) Shared power to vote or to direct the vote . 0 (iii) Amount beneficially owned: 939,888 * assumes warrants held by Kovitz clients exercised (iv) Shared power to dispose or to direct the disposition of . 0 Instruction. For computations regarding securities which represent a right to acquire an underlying security see ?240.13d-3(d)(1). Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ? . Instruction. Dissolution of a group requires a response to this item. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Item 8. Identification and Classification of Members of the Group. Item 9. Notice of Dissolution of Group. Item 10. Certification. (a) The following certification shall be included if the statement is filed pursuant to ?240.13d-1(b): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. (b) The following certification shall be included if the statement is filed pursuant to ?240.13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 08/08/2024 Date /s/ Signature Jeremy Wilson, CCO Name/Title
    Get the next $TNON alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $TNON

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TNON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Williamson Kevin

      3 - Tenon Medical, Inc. (0001560293) (Issuer)

      9/19/24 6:52:57 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • SEC Form 3 filed by new insider Jacques Kristine M

      3 - Tenon Medical, Inc. (0001560293) (Issuer)

      3/29/24 5:41:26 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Van Dick Steven M converted options into 1,522 shares, increasing direct ownership by 15% to 11,565 units (SEC Form 5)

      5 - Tenon Medical, Inc. (0001560293) (Issuer)

      2/13/24 4:48:49 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    SEC Filings

    See more
    • SEC Form 10-Q filed by Tenon Medical Inc.

      10-Q - Tenon Medical, Inc. (0001560293) (Filer)

      5/13/25 4:50:30 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by Tenon Medical Inc.

      424B3 - Tenon Medical, Inc. (0001560293) (Filer)

      4/16/25 4:00:27 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by Tenon Medical Inc.

      EFFECT - Tenon Medical, Inc. (0001560293) (Filer)

      4/16/25 12:15:20 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco

      LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced that Chief Financial Officer Kevin Williamson will host one-on-one investor meetings in San Francisco, CA during the week of January 13th in accordance with the 43rd Annual J.P. Morgan Healthcare Conference.The J.P. Morgan Healthcare Conference is the industry's leading global investment forum, bringing together top executives, investors, and innovators across the healthcare ecosystem. With over 500 healthcare companies presenting, the event showcases groundbreaking advanc

      1/9/25 8:00:00 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon Medical Reports Third Quarter 2024 Financial Results

      ~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL™ Study; Post-Market Study Supports the Safety and Efficacy of the Catamaran SI Joint Fusion System® Including Radiographic Proof of Fusion ~~ Initial Clinical Procedures Completed with New Catamaran SE Platform ~~ Granted Issuance of Three U.S. Patents ~~ Received Net Proceeds of ~$9.6 Million from Equity Financing Transactions ~ LOS GATOS, CA / ACCESSWIRE / November 13, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering from certain Sac

      11/13/24 4:05:00 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company's New Catamaran(R) SE SI Joint Fusion System

      ~ Procedures Completed in Various Spine & Pain Centers of Excellence Throughout the Country Including in Idaho, Pennsylvania, Minnesota, Arizona and Utah ~~Feedback From Initial Physician Users to Support Broader Market Introduction~ LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced completion of the initial clinical cases utilizing the Company's new Catamaran SE SI Joint Fixation Device. The new implant offers a 30% reduction in implant width as compared to the original Catamaran Fixation Device, providing physicians wi

      10/30/24 4:05:00 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    Leadership Updates

    Live Leadership Updates

    See more
    • Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer

      LOS GATOS, CA / ACCESSWIRE / August 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has appointed Kevin Williamson as Chief Financial Officer. Mr. Williamson's appointment succeeds the previously disclosed retirement of Steve Van Dick from the role of Chief Financial Officer.Mr. Williamson most recently served as the Chief Financial Officer at Accelus Inc., a medical device company focused on expandable spinal implant technology. In this role, Mr. Williamson was responsible for the finance organization, in addition to the investor relation

      8/27/24 4:05:00 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors

      Experienced Medical Devices Industry Executive Joins Tenon's Board of DirectorsLOS GATOS, CA / ACCESSWIRE / March 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced that Kristine Jacques has been appointed as an independent member of the Company's Board of Directors on March 25, 2024, effective immediately. Following this appointment, Tenon Medical's Board of Directors consists of seven members, including four independent directors.During her impressive career spanning over 35 years, Ms. Jacques brings extensive experience in various executive leadership roles in

      3/28/24 8:00:00 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Tenon Medical Inc.

      SC 13G - Tenon Medical, Inc. (0001560293) (Subject)

      10/4/24 1:21:56 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Tenon Medical Inc.

      SC 13G - Tenon Medical, Inc. (0001560293) (Subject)

      8/8/24 4:07:29 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Tenon Medical Inc.

      SC 13G/A - Tenon Medical, Inc. (0001560293) (Subject)

      8/8/24 4:02:25 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    Financials

    Live finance-specific insights

    See more
    • Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results

      LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the third quarter 2024 ended September 30, 2024 after market close on Wednesday, November 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.Date:Wednesday, November 13, 2024Time:4:30 p.m. Eastern timeDial-in:1-800-717-1738International Dial-in:1-646-307-1865Webcast:TNON C

      10/30/24 8:00:00 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon Medical Reports Second Quarter 2024 Financial Results

      ~ Second Quarter 2024 Revenue Increased 21% Year-Over-Year ~~ Surgical Procedures Increased 7% Year-Over-Year in the Second Quarter 2024 ~~ Gross Profit Margin of 52% Marks One Year of Generating Positive Gross Profit ~~ Publication of Post-Market Study Interim Analysis Now Imminent ~ LOS GATOS, CA / ACCESSWIRE / August 13, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today reported financial results for the second quarter ended June 30, 2024.Second Quarter 2024 and Subsequent HighlightsRevenue of $901,000 in the second quarter of 2024, a 21% increase over th

      8/13/24 4:05:00 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results

      LOS GATOS, CA / ACCESSWIRE / July 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the second quarter 2024 ended June 30, 2024 after market close on Tuesday, August 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.Date:Tuesday, August 13, 2024Time:4:30 p.m. Eastern timeDial-in:1-877-407-0792International Dial-in:1-201-689-8263Webcast:TNON Conference

      7/30/24 8:00:00 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care